Beactica Therapeutics AB: Beactica Therapeutics to present u

STOCKHOLM, April 11, 2023 /PRNewswire/ -- Beactica Therapeutics AB, the Swedish precision oncology company, today announced that its LSD1 programme has been selected for a poster presentation

Related Keywords

Florida , United States , Stockholm , Sweden , Orange County Convention Center , Orlando , Swedish , American , Konrad Koehler , American Association For Cancer Research , American Association For Cancer Research Annual Meeting , Drug Administration , American Association , Cancer Research , Annual Meeting , Sunday April , Abstract Presentation Number , Orphan Drug Designation , Beactica , Herapeutics , Present , Update , Csd1 , Programme , Racr , Nnual , Meeting , 023 ,